Southern Research has helped biopharma innovators turn bold immunotherapy ideas into clinic-ready realities for more than eighty years. We provide a seamless suite of immunogenicity and translational immunology services that spans ADA and neutralizing-antibody analyses, cytokine-release and T-cell functional assays, and rapid, multi-species efficacy models that mirror today’s checkpoint-inhibitor, mRNA/LNP and cell-therapy pipelines. Our evaluation strategy bundles assay design, bioanalysis and regulatory-grade reporting, trimming decision-making timelines while giving sponsors budget clarity. At the Immunotherapies Exchange, we look forward to exploring how our collaborative scientists can become an extension of your team, translating mechanistic insight into clear go/no-go choices that accelerate immune-modulating candidates toward first-in-human studies.